VEGFA and neoplasm: TAMs facilitate tumor progression by promotion of angiogenesis (44–46), secretion of growth factors such as TGFβ and vascular endothelial growth factor (VEGF) (30–33), and suppression of antitumor lymphocytes (31, 47–49).